VIEMED HEALTHCARE, INC.

Annual Trend FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Revenue $64.5m
$80.3m +24.50%
$131.3m +63.61%
$117.1m -10.85%
$138.8m +18.60%
$183.0m +31.82%
$224.3m +22.54%
$270.3m +20.52%
$301.6m +11.59%
Cost of revenue $16.7m
$24.2m +45.31%
$51.2m +111.13%
$43.7m -14.74%
$54.2m +24.05%
$70.2m +29.68%
$91.1m +29.66%
$114.8m +26.10%
$128.3m +11.72%
Gross profit $47.8m
$56.0m +17.23%
$80.1m +43.04%
$73.4m -8.36%
$84.7m +15.35%
$112.8m +33.19%
$133.2m +18.11%
$155.5m +16.71%
$173.3m +11.49%
Research and development $0 $848k $1.1m $2.1m $2.7m $2.8m $3.1m $3.0m $2.5m
Selling, general and administrative $34.3m $41.4m $52.8m $54.9m $68.2m $87.9m $106.2m $121.4m $145.0m
Income from operations $10.1m
$8.9m -11.92%
$26.8m +202.37%
$11.6m -56.76%
$8.3m -28.74%
$14.3m +73.65%
$17.9m +24.91%
$22.9m +28.21%
$24.5m +6.71%
Interest expense, net $181k $314k $509k $318k ($197k) ($424k) ($776k) ($1.2m) $1.3m
Other expense (income), net $3k ($4.0m) ($1.6m) ($989k) ($98k) $173k ($252k)
Net income before taxes $9.7m $8.8m $26.4m $12.5m $9.0m $14.4m $16.2m $21.8m
Provision for income taxes $162k $271k ($5.2m) $3.4m $2.8m $4.1m $4.8m $6.4m
Net income $9.5m
$8.5m -10.34%
$31.5m +269.85%
$9.1m -71.06%
$6.2m -31.82%
$10.2m +64.63%
$11.4m +11.38%
$15.4m +34.77%
$14.5m -5.71%
Net income attributable to Viemed Healthcare, Inc. $9.5m $8.5m $31.5m $9.1m $6.2m $10.2m $11.3m $14.9m $14.5m
Net income attributable to noncontrolling interest $0 $0 $144k $442k
Basic (in USD per share) $0.26 $0.23 $0.68 $0.32 $0.23 $0.38 $0.42 $0.56
Diluted (in USD per share) $0.24 $0.22 $0.65 $0.31 $0.23 $0.36 $0.40 $0.53
Stock-based compensation $2.7m $3.9m $4.9m $5.2m $5.2m $5.8m $6.3m $9.1m
Depreciation and amortization $588k $671k $816k $851k $1.0m $1.4m $1.5m $1.5m $1.6m
Loss (gain) on disposal of property and equipment $54k $360k ($2.3m) $448k $346k $645k ($1.9m) ($2.2m)
Income (loss) from investments $110k ($91k) ($1.2m) $935k $485k ($954k) $0